Zero-fluoroscopy cardioneuroablation was presented as a treatment approach for a pregnant woman with cardioinhibitory neurally mediated syncope.
Case Report (n=1)
Zero-fluoroscopy cardioneuroablation may be a feasible treatment for recurrent, disabling cardioinhibitory neurally mediated syncope in pregnant patients.
Cardioneuroablation (CNA) is an interventional therapy aimed at modulating cardiac autonomic function through the selective ablation of parasympathetic ganglionated plexi (GP). By modulating vagal inputs to the sinus and atrioventricular nodes, CNA has emerged as a potential treatment for selected patients with cardioinhibitory neurally mediated syncope (NMS), particularly when symptoms are recurrent and disabling, in the absence of structural heart disease.
Saviano et al. (Mon,) conducted a case report in Cardioinhibitory neurally mediated syncope (n=1). Zero-fluoroscopy cardioneuroablation was evaluated. Zero-fluoroscopy cardioneuroablation was presented as a treatment approach for a pregnant woman with cardioinhibitory neurally mediated syncope.